Company intelligence / Profile preview
Regent Pacific Group
- Ownership
- Private
- Employees
- ~17
- Development stage
- Other
Overview
Regent Pacific Group is a Hong Kong-based investment holding company focused on growth and value-led investments in healthcare and late-stage life sciences. It operates primarily through two segments—Biopharma and Corporate Investment—holding stakes in pharmaceutical R&D, manufacturing, marketing of products for urological disorders, and AI systems for tracking biological aging. The group builds its portfolio to commercialize assets via outlicensing to strategic pharma partners.
- Therapeutic areas
- Men's HealthOther
- Modalities
- Small molecule (via portfolio companies)Artificial intelligence system for biological aging clocksOther modalities possible via investments
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Regent Pacific Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regent Pacific Group.